{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:05:21Z","timestamp":1790233521800,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1124\/dmd.32.4.468","type":"journal-article","created":{"date-parts":[[2004,3,23]],"date-time":"2004-03-23T22:08:14Z","timestamp":1080079694000},"page":"468-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR"],"prefix":"10.1016","volume":"32","author":[{"given":"Kaoru","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakiyo","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.32.4.468_bib1","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","article-title":"Identification of a human nuclear receptor defined a new signaling pathway for CYP3A induction.","volume":"95","author":"Bertilsson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.32.4.468_bib2","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1101\/gad.12.20.3195","article-title":"SXR, a novel steroid and xenobiotic-sensing nuclear receptor.","volume":"12","author":"Blumberg","year":"1998","journal-title":"Genes Dev"},{"key":"10.1124\/dmd.32.4.468_bib3","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/0006-2952(83)90178-8","article-title":"Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.","volume":"32","author":"Delaforge","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.32.4.468_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/dmd.30.1.96","article-title":"A pharmacophore for human pregnane X receptor ligands.","volume":"30","author":"Ekins","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.4.468_bib5","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1074\/jbc.M010173200","article-title":"Nuclear receptor response elements mediated induction of intestinal MDR1 by rifampin.","volume":"276","author":"Geick","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.32.4.468_bib6","first-page":"1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.32.4.468_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.42.111901.111051","article-title":"Regulation of cyp3a gene transcription by the pregnane x receptor.","volume":"42","author":"Goodwin","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.32.4.468_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/mend.14.1.0409","article-title":"The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.","volume":"14","author":"Jones","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/dmd.32.4.468_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11626-998-0092-z","article-title":"Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines.","volume":"34","author":"Kawada","year":"1998","journal-title":"In Vitro Cell Dev Biol"},{"key":"10.1124\/dmd.32.4.468_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"key":"10.1124\/dmd.32.4.468_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.","volume":"102","author":"Lehmann","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1124\/dmd.32.4.468_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(95)03155-9","article-title":"Substrates of human hepatic cytochrome P450 3A4.","volume":"104","author":"Li","year":"1995","journal-title":"Toxicology"},{"key":"10.1124\/dmd.32.4.468_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","article-title":"CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes.","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.4.468_bib14","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","article-title":"Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.","volume":"275","author":"Moore","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.32.4.468_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/abbi.1996.0159","article-title":"Distinct effects of phenobarbital and its M-methylated derivative on liver cytochrome P450 induction.","volume":"328","author":"Murayama","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.32.4.468_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0090-9556(25)08600-3","article-title":"Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.","volume":"18","author":"Pichard","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.4.468_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/87856","article-title":"Promiscuous regulator of xenobiotic removal.","volume":"7","author":"Schuetz","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/dmd.32.4.468_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/87912","article-title":"The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.","volume":"7","author":"Synold","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/dmd.32.4.468_bib19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/bi0268753","article-title":"2.1 \u00c5 crystal structure of human PXR in complex with the St. John\u2019s wort compound hyperforin.","volume":"42","author":"Watkins","year":"2003","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.32.4.468_bib20","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1126\/science.1060762","article-title":"The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity.","volume":"292","author":"Watkins","year":"2001","journal-title":"Science (Wash DC)"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.32.4.468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:57:10Z","timestamp":1739897830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624028976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0090955624028976"],"URL":"https:\/\/doi.org\/10.1124\/dmd.32.4.468","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.32.4.468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}